These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma. Xu X, Sun ZY, Wu HW, Zhang CP, Hu B, Rong L, Chen HY, Xie HY, Wang YM, Lin HP, Bai YR, Ye Q, Ma XM. Radiat Oncol; 2021 Jul 19; 16(1):132. PubMed ID: 34281566 [Abstract] [Full Text] [Related]
24. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers. Lin P, Min M, Lee M, Holloway L, Forstner D, Bray V, Fowler A. Eur J Nucl Med Mol Imaging; 2017 May 19; 44(5):801-811. PubMed ID: 28004135 [Abstract] [Full Text] [Related]
36. A pilot study for texture analysis of 18F-FDG and 18F-FLT-PET/CT to predict tumor recurrence of patients with colorectal cancer who received surgery. Nakajo M, Kajiya Y, Tani A, Jinguji M, Nakajo M, Kitazono M, Yoshiura T. Eur J Nucl Med Mol Imaging; 2017 Dec 19; 44(13):2158-2168. PubMed ID: 28770274 [Abstract] [Full Text] [Related]
37. (18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status. Lovinfosse P, Koopmansch B, Lambert F, Jodogne S, Kustermans G, Hatt M, Visvikis D, Seidel L, Polus M, Albert A, Delvenne P, Hustinx R. Br J Radiol; 2016 Jul 19; 89(1063):20160212. PubMed ID: 27146067 [Abstract] [Full Text] [Related]
38. Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial. Guido A, Cuicchi D, Castellucci P, Cellini F, Di Fabio F, Llimpe FLR, Strigari L, Buwenge M, Cilla S, Deodato F, Macchia G, Galietta E, Golfieri R, Ardizzoni A, Zagari RM, Fanti S, Poggioli G, Fuccio L, Morganti AG. Eur J Nucl Med Mol Imaging; 2023 Jan 19; 50(2):572-580. PubMed ID: 36127416 [Abstract] [Full Text] [Related]
39. Intratumoral heterogeneity in 18F-FDG PET/CT by textural analysis in breast cancer as a predictive and prognostic subrogate. Molina-García D, García-Vicente AM, Pérez-Beteta J, Amo-Salas M, Martínez-González A, Tello-Galán MJ, Soriano-Castrejón Á, Pérez-García VM. Ann Nucl Med; 2018 Jul 19; 32(6):379-388. PubMed ID: 29869770 [Abstract] [Full Text] [Related]
40. Heterogeneity index evaluated by slope of linear regression on 18F-FDG PET/CT as a prognostic marker for predicting tumor recurrence in pancreatic ductal adenocarcinoma. Kim YI, Kim YJ, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kang KW. Eur J Nucl Med Mol Imaging; 2017 Nov 19; 44(12):1995-2003. PubMed ID: 28634684 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]